ALFA reports 2Q24 EBITDA of US $445 million and raises its 2024 Guidance

In This Article:

SAN PEDRO GARZA GARCíA, N.L., Mexico, July 24, 2024 /PRNewswire/ -- ALFA, S.A.B. de C.V. (BMV: ALFAA) ("ALFA") announced today its unaudited results for the second quarter of 2024 ("2Q24"). All figures have been prepared in accordance with International Financial Reporting Standards ("IFRS").

2Q24 HIGHLIGHTS

ALFA

?  Accumulated EBITDA of US $870 million, up 18% year-over-year driven mainly by Sigma. ALFA's 2024 EBITDA Guidance increased 5% to US $1.590 billion to incorporate upward revision from Sigma

?  ALFA actively pursuing debt reduction initiatives to complete transformation; various non-core asset sale processes advanced further

?  Consolidated Net Leverage ratio of 3.3 times; Alpek 3.3x and Sigma 2.0x

Sigma

?  Thirteenth consecutive quarter of year-on-year sales growth supported by record volume of 462 ktons, up 3% versus 2Q23

?  Accumulated EBITDA of US $542 million, up 33% year-on-year driven by strong growth across all regions

?  Upward Guidance revision: Sigma's 2024 EBITDA expected to reach historic milestone of US $1.0 billion, 9% higher than original estimate

?  Net Leverage ratio of 2.0 times represents lowest level in nearly 11 years

Alpek

?  Accumulated Comparable EBITDA of US $312 million is on track to reach full-year guidance of US $600 million. The global petrochemical industry continued to face certain headwinds such as low reference margins

?  Completed structural cost reduction initiatives which are expected to deliver US $75 million in annualized cost savings

?  Net Debt decreased 5% quarter on quarter driven by solid cash flow

Message from ALFA's Chairman & CEO

"ALFA's consolidated results exceeded our initial estimations as both business units continued to successfully capitalize on resilient demand and better-than-expected dynamics in the food sector. EBITDA grew at double-digit rates year-on-year in 2Q24 and the first half of 2024 (1H24) driven by Sigma, which is key to completing ALFA's transformational process.

Alpek's Comparable EBITDA of US $312 million during the first half of 2024 is on track to meet our petrochemical business' expectations for the full year. In addition, Alpek completed its structural cost reduction initiatives which are expected to deliver US $75 million in annualized cost savings to mitigate the impact of sustained global industry headwinds.

Sigma maintained its growth momentum, reporting the thirteenth consecutive quarter of year-on-year increase in Revenues. Moreover, EBITDA reached a new quarterly record-high of US $279 million. Importantly, all regions contributed to these strong results, including outstanding performance in Mexico and the U.S.